LATEST NEWS :
Mentorship Program For UPSC and UPPCS separate Batch in English & Hindi . Limited seats available . For more details kindly give us a call on 7388114444 , 7355556256.
asdas
Print Friendly and PDF

RNA Therapy

31.01.2025

 

RNA Therapy

 

For Prelims: About RNA Therapy, Applications of RNA based Therapies

 

Why in the news?                        

In recent days RNA-based precision therapeutics are emerging as a game-changer for genetic disorders, including inherited retinal diseases (IRDs).

 

About RNA Therapy:

  • It is a term used to describe the use of RNA-based molecules to modulate biological pathways to cure a specific condition.
  • Unlike gene-editing therapies, RNA-based therapies offer a safer alternative as they make temporary changes that do not carry over to future generations, reducing the risk of unintended long-term effects.

Applications of RNA based Therapies:

  • RNA-editing with ADAR enzymes: It can correct specific genetic mutations at the RNA level. This method has the potential to restore protein production in retinal cells without altering the underlying DNA, offering a new way to treat retinal degenerative diseases caused by single-point mutations.
  • Using of suppressor tRNAs: It is to bypass stop-codon mutations, which can prematurely halt protein synthesis in retinal cells. By enabling the production of full-length proteins, this approach could help restore proper retinal function in IRD patients.
  • PTC124 Method: It is also known as ataluren, which is already being used to treat patients with cystic fibrosis and Duchenne muscular dystrophy.
  • Antisense oligonucleotides (ASOs) have already been used successfully to treat diseases such as spinal muscular atrophy and Duchenne muscular dystrophy.

                                                           Source: The Hindu

Consider the following statements regarding RNA Therapy:

Statement-I: It uses RNA-based molecules to modulate biological pathways to cure a specific condition.

Statement-II: It cannot be used in Duchenne muscular dystrophy treatment

 

Which one of the following is correct in respect of the above statements?

A.Both Statement-I and Statement-II are correct, and Statement-II is the correct explanation for Statement-I.

B.Both Statement-I and Statement-II are correct, and Statement-II is not the correct explanation for Statement-I.

C.Statement-I is correct, but Statement-II is incorrect.

D.Statement-I is incorrect, but Statement-II is correct.

 

 

Answer C

Get a Callback